Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC
Clinical trial NCT05583188 · TERMINATED
Trial details
- NCT number
- NCT05583188
- Sponsor
- Galvanize Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2024-02-08
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.